172 related articles for article (PubMed ID: 11804278)
1. Gliomatosis cerebri: post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide.
Mawrin C; Aumann V; Kirches E; Schneider-Stock R; Scherlach C; Vogel S; Mittler U; Dietzmann K; Krause G; Weis S
J Neurooncol; 2001 Oct; 55(1):11-7. PubMed ID: 11804278
[TBL] [Abstract][Full Text] [Related]
2. Analysis of TP53 and PTEN in gliomatosis cerebri.
Mawrin C; Kirches E; Schneider-Stock R; Scherlach C; Vorwerk C; Von Deimling A; Van Landeghem F; Meyermann R; Bornemann A; Müller A; Romeike B; Stoltenburg-Didinger G; Wickboldt J; Pilz P; Dietzmann K
Acta Neuropathol; 2003 Jun; 105(6):529-36. PubMed ID: 12734658
[TBL] [Abstract][Full Text] [Related]
3. Gliomatosis cerebri: molecular pathology and clinical course.
Herrlinger U; Felsberg J; Küker W; Bornemann A; Plasswilm L; Knobbe CB; Strik H; Wick W; Meyermann R; Dichgans J; Bamberg M; Reifenberger G; Weller M
Ann Neurol; 2002 Oct; 52(4):390-9. PubMed ID: 12325066
[TBL] [Abstract][Full Text] [Related]
4. [Gliomatosis cerebri: report of 3 cases and review of recent literatures].
Arai M; Kashihara K; Kaizaki Y; Taguchi M; Kitamura Y
No To Shinkei; 2003 Oct; 55(10):890-7. PubMed ID: 14635518
[TBL] [Abstract][Full Text] [Related]
5. Distribution of p53 alterations in a case of gliomatosis cerebri.
Mawrin C; Lins H; Kirches E; Schildhaus HU; Scherlach C; Kanakis D; Dietzmann K
Hum Pathol; 2003 Jan; 34(1):102-6. PubMed ID: 12605375
[TBL] [Abstract][Full Text] [Related]
6. [Gliomatosis cerebri: a biopsy and autopsy case report].
San Millan B; Kaci R; Polivka M; Robert G; Héran F; Gueguen A; Mokhtari K; Gray F
Ann Pathol; 2010 Feb; 30(1):25-9. PubMed ID: 20223351
[TBL] [Abstract][Full Text] [Related]
7. Pilocytic astrocytoma presenting as primary diffuse leptomeningeal gliomatosis: report of a unique case and review of the literature.
Bohner G; Masuhr F; Distl R; Katchanov J; Klingebiel R; Zschenderlein R; von Deimling A; van Landeghem FK
Acta Neuropathol; 2005 Sep; 110(3):306-11. PubMed ID: 16003541
[TBL] [Abstract][Full Text] [Related]
8. Alterations of cell cycle regulators in gliomatosis cerebri.
Mawrin C; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Deimling A; Stoltenburg-Didinge G; Bornemann A; Romeike B; Sellhaus B; Dietzmann K
J Neurooncol; 2005 Apr; 72(2):115-22. PubMed ID: 15925990
[TBL] [Abstract][Full Text] [Related]
9. [Glioblastoma multiforme developing separately from the initial lesion 9 years after successful treatment for gliomatosis cerebri: a case report].
Inoue T; Kanamori M; Sonoda Y; Watanabe M; Sasajima T; Kamisato N; Kumabe T; Tominaga T
No Shinkei Geka; 2008 Aug; 36(8):709-15. PubMed ID: 18700534
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of radiographically defined de novo glioblastoma multiforme.
Tortosa A; Ino Y; Odell N; Swilley S; Sasaki H; Louis DN; Henson JW
Neuropathol Appl Neurobiol; 2000 Dec; 26(6):544-52. PubMed ID: 11123721
[TBL] [Abstract][Full Text] [Related]
11. Initial chemotherapy in gliomatosis cerebri.
Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
[TBL] [Abstract][Full Text] [Related]
12. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C
Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489
[TBL] [Abstract][Full Text] [Related]
13. [Gliomatosis cerebri].
Sanson M; Napolitano M; Cartalat-Carel S; Taillibert S
Rev Neurol (Paris); 2005 Feb; 161(2):173-81. PubMed ID: 15798516
[TBL] [Abstract][Full Text] [Related]
14. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
[TBL] [Abstract][Full Text] [Related]
15. Gliomatosis of the brain and spinal cord masquerading as infective lesions.
Meligonis G; Sur M; Ouma J; Grayson W; Farrell VJ
Surg Neurol; 2002 Jun; 57(6):399-404; discussion 404. PubMed ID: 12176200
[TBL] [Abstract][Full Text] [Related]
16. Gliomatosis cerebri.
Gleizniene R; Bucinskas U; Lukosevicius S; Vaitkus A; Letautiene S; Apanaviciūte D; Galvonaite M
Medicina (Kaunas); 2010; 46(5):341-4. PubMed ID: 20679750
[TBL] [Abstract][Full Text] [Related]
17. [Gliomatosis cerebri].
Masuoka J; Tabuchi K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():128-32. PubMed ID: 16201512
[No Abstract] [Full Text] [Related]
18. Independent molecular development of metachronous glioblastomas with extended intervening recurrence-free interval.
Martinez R; Schackert HK; von Kannen S; Lichter P; Joos S; Schackert G
Brain Pathol; 2003 Oct; 13(4):598-607. PubMed ID: 14655763
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri.
Braeuninger S; Schneider-Stock R; Kirches E; Powers JM; Korones DN; Mawrin C
J Neurooncol; 2007 Mar; 82(1):23-7. PubMed ID: 16955219
[TBL] [Abstract][Full Text] [Related]
20. Gliomatosis cerebri in a patient with Ollier disease.
Mitchell RA; Ye JM; Mandelstam S; Lo P
J Clin Neurosci; 2011 Nov; 18(11):1564-6. PubMed ID: 21868231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
